Impact BioMedical, Inc. (IBO)

US · Healthcare · Biotechnology

$0.57+14.74%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$3,000

Revenue YoY

-57.1%

Net profit

$-699,000

EPS

$-0.01

Net margin

-23,300.0%

Market cap

$49.6M

P/E

0.5

Forward P/E

0.0

P/B

4.61

Book value

$0.10

EPS (TTM)

$0.88

52-week high

$0.83

52-week low

$0.37

50-day MA

$0.45

200-day MA

$0.51

Insiders

89.02%

Institutions

3.56%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Impact BioMedical, Inc. — free to start.

Data updated 2026-09-18.